Technosphere inhaled insulin is entering phase III clinical trials, according to manufacturer MannKind Corporation. Successful phase III trials are typically the last step before a drug is submitted to the U.S. FDA for regulatory review.
The drug, which was developed by insulin pump pioneer Al Mann, uses the proprietary MedTone inhaler device that administers the insulin. The inhaler fits in the palm of your hand and, all other things being equal, the convenience of the device over Exubera's comparatively bulkier delivery system could be a big plus when it finally comes to market.
dLife Today:
Entradas
No hay comentarios:
Publicar un comentario